From 2013 to 2023, antidepressant sales in Canada experienced a consistent decline, with a noticeable drop from 5.9 in 2013 to 3.9 in 2023. The year 2015 saw a significant 10.17% decrease. The calculated CAGR over the past five years leading up to 2023 was -1.47%, indicating a steady reduction in sales. Forecasted data from 2024 to 2028 suggests a further decline, with a projected CAGR of -2.26%, leading to an overall decrease of 10.81% by 2028.
- Monitor changes in healthcare policies and mental health awareness initiatives.
- Observe potential innovations in treatment options that may impact medication usage.
- Watch for the influence of societal factors and economic conditions on mental health trends.
